{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:43:44Z","timestamp":1793774624922,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.adro.2023.101270","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T17:39:45Z","timestamp":1684690785000},"page":"101270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Single-Institution Prospective Evaluation of Moderately Hypofractionated Whole-Breast Radiation Therapy With Simultaneous Integrated Boost With or Without Lymphatic Drainage Irradiation After Breast-Conserving Surgery"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8746-3814","authenticated-orcid":false,"given":"Olga","family":"Unterkirhere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stenger-Weisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kaever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hoeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Logaritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Glanzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Studer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2023.101270_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0002","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1259\/0007-1285-25-300-636","article-title":"Radiotherapy in breast cancer. I. The dose-time relationship theoretical considerations","volume":"25","author":"Cohen","year":"1952","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2023.101270_bib0003","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0360-3016(82)90062-1","article-title":"Superfractionation: Its rationale and anticipated benefits","volume":"8","author":"Douglas","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101270_bib0004","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","article-title":"Randomized trial of breast irradiation schedules after lumpectomy for women with lymph nodenegative breast cancer","volume":"94","author":"Whelan","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2023.101270_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: Long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0006","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"9","author":"Bentzen","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0007","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2023.101270_bib0008","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: A randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0009","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: The DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.adro.2023.101270_bib0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2022.07.2320","article-title":"NRG RTOG 1005: A phase III trial of hypo fractionated whole breast irradiation with concurrent boost vs. conventional whole breast irradiation plus sequential boost following lumpectomy for high risk early-stage breast cancer","volume":"114","author":"Vicini","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101270_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0012","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijrobp.2020.12.005","volume":"109","author":"H\u00f6rner-Rieber","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101270_bib0013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jnci.2017.01.005","volume":"29","author":"Mondal","year":"2017","journal-title":"J Egypt Natl Cancer Inst"},{"key":"10.1016\/j.adro.2023.101270_bib0014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1748-717X-7-145","article-title":"Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: A report of feasibility and early toxicity results in the first 50 treatments","volume":"7","author":"Scorsetti","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.breast.2018.08.098","article-title":"Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature","volume":"42","author":"De Rose","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.adro.2023.101270_bib0016","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1200\/JCO.2006.09.1041","article-title":"Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue","volume":"25","author":"Formenti","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clbc.2011.09.002","article-title":"Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer","volume":"12","author":"Chadha","year":"2012","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.adro.2023.101270_bib0018","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijrobp.2011.11.025","article-title":"Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy","volume":"83","author":"Ciervide","year":"2012","journal-title":"Int J Radiation Oncol Biol Phys"},{"issue":"4 suppl","key":"10.1016\/j.adro.2023.101270_bib0019","article-title":"Abstract GS4-05: Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK\/06\/003)","volume":"79","author":"Coles","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.adro.2023.101270_bib0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1748-717X-7-80","article-title":"Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial","volume":"7","author":"Van Parijs","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0021","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.breast.2022.05.008","article-title":"Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials","volume":"64","author":"Pfaffendorf","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.adro.2023.101270_bib0022","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000439007","article-title":"Hypofractionated radiotherapy as adjuvant treatment in early breast cancer. A review and meta-analysis of randomized controlled trials","volume":"10","author":"Budach","year":"2015","journal-title":"Breast Care"},{"key":"10.1016\/j.adro.2023.101270_bib0042","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.prro.2019.11.007","article-title":"Patterns of failure observed in the 2-step institution credentialing process for NRG Oncology\/Radiation Therapy Oncology Group 1005(NCT01349322) and lessons learned","volume":"10","author":"Li","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0023","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Eng J Med"},{"key":"10.1016\/j.adro.2023.101270_bib0024","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.adro.2023.101270_bib0025","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0026","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0027","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ijrobp.2013.03.021","article-title":"Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy","volume":"86","author":"Hennequin","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101270_bib0028","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2017.10.033","article-title":"START Trialists' Group. Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials","volume":"126","author":"Haviland","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0029","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/S0167-8140(21)06840-7","article-title":"OC-0291 IMPORT HIGH trial: Dose escalated simultaneous integrated boost radiotherapy in early breast cancer","volume":"161","author":"Coles","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0030","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ijrobp.2020.07.2313","article-title":"Hypofractionated adjuvant radiation therapy is effective for patients with lymph node-positive breast cancer: A population-based analysis","volume":"108","author":"Koulis","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101270_bib0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0032","unstructured":"White J, Arthur D NRG Breast Cancer Atlas for Radiation Therapy Planning. Consensus Definition. Available at: https:\/\/www.nrgoncology.org\/About-Us\/Center-for-Innovation-in-Radiation-Oncology\/Breast-Cancer\/RADCOMP-Breast-Atlas. Accessed June 20, 2023."},{"key":"10.1016\/j.adro.2023.101270_bib0033","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE). Available at: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm. Accessed June 20, 2023."},{"key":"10.1016\/j.adro.2023.101270_bib0034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-8140(95)90055-1","article-title":"LENT SOMA tables","volume":"35","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0360-3016(79)90729-6","article-title":"Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast","volume":"5","author":"Harris","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101270_bib0036","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","article-title":"HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - Interim analysis","volume":"174","author":"Chakraborty","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2023.101270_bib0037","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/s13063-020-04751-y","volume":"21","author":"Chatterjee","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.adro.2023.101270_bib0038","first-page":"2513","article-title":"Hypofractionated radiotherapy for breast cancer including risk-adapted boost: Update on tolerance and efficacy of an accelerated START A regime","volume":"35","author":"Janssen","year":"2016","journal-title":"Anticancer Research Res"},{"key":"10.1016\/j.adro.2023.101270_bib0039","series-title":"Mittelfristige Behandlungs-Toleranz nach akzelerierter hypofraktionierter Radiotherapie (2.66Gy) nach organerhaltend operiertem Brust-Karzinom. Inaugural dissertation","author":"Giani","year":"2016"},{"key":"10.1016\/j.adro.2023.101270_bib0040","first-page":"48","article-title":"Hypofractionated post-radiation with integrated boost in breast carcinoma: First results of the multicentre ARO 2014 04 study","volume":"197","author":"Dinges","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2023.101270_bib0041","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2021.09.006","article-title":"Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost","volume":"164","author":"Franceschini","year":"2021","journal-title":"Radiother Oncology"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:43:30Z","timestamp":1762530210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109423000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2452109423000994"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2023.101270","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-Institution Prospective Evaluation of Moderately Hypofractionated Whole-Breast Radiation Therapy With Simultaneous Integrated Boost With or Without Lymphatic Drainage Irradiation After Breast-Conserving Surgery","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2023.101270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101270"}}